PhoenixBio Co., Ltd. (6190.T)
JPY 328.0
(-1.2%)
JPY 328.0
(-1.2%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 1.19 Billion JPY | -23.22% |
| 2022 | 1.55 Billion JPY | 113.86% |
| 2021 | 727.79 Million JPY | 23.74% |
| 2020 | 588.14 Million JPY | -32.01% |
| 2019 | 865 Million JPY | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 335 Million JPY | 9.44% |
| 2023 Q2 | 292.32 Million JPY | 5.0% |
| 2023 Q4 | 306.11 Million JPY | -3.81% |
| 2023 Q3 | 318.22 Million JPY | 8.86% |
| 2023 FY | 1.19 Billion JPY | -23.22% |
| 2023 Q1 | 278.39 Million JPY | -13.14% |
| 2022 Q2 | 544.77 Million JPY | 0.0% |
| 2022 FY | 1.55 Billion JPY | 113.86% |
| 2022 Q4 | 320.51 Million JPY | -11.94% |
| 2022 Q3 | 363.98 Million JPY | -33.19% |
| 2021 FY | 727.79 Million JPY | 23.74% |
| 2020 FY | 588.14 Million JPY | -32.01% |
| 2019 FY | 865 Million JPY | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| KOHJIN BIO CO LTD | 1.88 Billion JPY | 36.477% |
| PRISM BioLab Co.,LTD | 80.3 Million JPY | -1388.13% |
| GNI Group Ltd. | 22.43 Billion JPY | 94.672% |
| Linical Co., Ltd. | 3.77 Billion JPY | 68.37% |
| Trans Genic Inc. | 2.24 Billion JPY | 46.869% |
| MEDINET Co., Ltd. | 98.25 Million JPY | -1116.319% |
| Soiken Holdings Inc. | 2.48 Billion JPY | 51.858% |
| Cytori Cell Research Institute, Inc. | 1.29 Billion JPY | 7.547% |
| AnGes, Inc. | -3.06 Billion JPY | 138.987% |
| OncoTherapy Science, Inc. | -177.71 Million JPY | 772.446% |
| Nxera Pharma Co., Ltd. | 9.66 Billion JPY | 87.634% |
| Immuno-Biological Laboratories Co., Ltd. | 517.29 Million JPY | -131.021% |
| NanoCarrier Co., Ltd. | 110.95 Million JPY | -977.056% |
| Carna Biosciences, Inc. | 1.45 Billion JPY | 17.616% |
| CanBas Co., Ltd. | -984 Million JPY | 221.449% |
| D. Western Therapeutics Institute, Inc. | 391.69 Million JPY | -205.097% |
| RaQualia Pharma Inc. | 1.65 Billion JPY | 27.841% |
| Chiome Bioscience Inc. | 398.59 Million JPY | -199.818% |
| Kidswell Bio Corporation | 1.03 Billion JPY | -14.978% |
| PeptiDream Inc. | 17.21 Billion JPY | 93.06% |
| Oncolys BioPharma Inc. | 30.6 Million JPY | -3804.78% |
| Ribomic Inc. | -10.5 Million JPY | 11479.337% |
| SanBio Company Limited | -14.5 Million JPY | 8339.506% |
| Healios K.K. | 108 Million JPY | -1006.535% |
| BrightPath Biotherapeutics Co., Ltd. | -341 Thousand JPY | 350556.891% |
| Kubota Pharmaceutical Holdings Co., Ltd. | -59.04 Million JPY | 2123.944% |
| Delta-Fly Pharma, Inc. | -1.51 Million JPY | 79138.228% |
| StemRIM | -44.34 Million JPY | 2794.667% |
| CellSource Co., Ltd. | 3.18 Billion JPY | 62.479% |
| FunPep Company Limited | -680.28 Million JPY | 275.67% |
| Kringle Pharma, Inc. | 69.25 Million JPY | -1625.716% |
| Stella Pharma Corporation | 217.29 Million JPY | -449.963% |
| TMS Co., Ltd. | -6.95 Million JPY | 17295.079% |
| Noile-Immune Biotech Inc. | 314.56 Million JPY | -279.913% |
| Cuorips Inc. | 9.63 Million JPY | -12308.452% |
| K Pharma,Inc. | 910 Million JPY | -31.325% |
| Takara Bio Inc. | 25.45 Billion JPY | 95.306% |
| ReproCELL Incorporated | 1.1 Billion JPY | -8.177% |
| StemCell Institute Inc. | 1.57 Billion JPY | 24.166% |
| Japan Tissue Engineering Co., Ltd. | 1.66 Billion JPY | 28.302% |
| CellSeed Inc. | 107.15 Million JPY | -1015.261% |